Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-02-26 @ 4:19 PM
Study NCT ID:
NCT01761266
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2013-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
Sponsor:
Eisai Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-02
First Submit QC Date:
None
Study First Post Date:
2013-01-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-27
Results First Submit QC Date:
None
Results First Post Date:
2018-09-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-01-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-08
Last Update Post Date:
2022-04-05
Last Update Post Date Type:
ACTUAL